Immunoassays comprise a wide range of bioanalytical tools critical to scientific and clinical research, but for all their variety and ubiquity, the method is often labor-intensive, time-consuming, and requires specialized skills. Bio-Techne’s fully automated immunoassay platform—Ella—tackles these tedious issues with new levels of throughput, automation, sensitivity, and reliability.
Ella’s pre-loaded Simple Plex cartridges contain fully validated assays powered by R&D Systems—the industry leader in immunoassays—to deliver fast, reproducible data with no manual steps. A unique microfluidic cartridge design means assays run on Ella are fast, hands-free, and reproducible. Because Simple Plex assays are precisely controlled in the cartridge, there’s no potential for pipetting errors. Simple dilution replaces manual preparations that consume valuable lab resources and can introduce user variability; compared to standard ELISA, Ella can reduce manual steps by a remarkable 80%. Pre-loaded standard curves help save analysis time and maximize data.
All told, from the start of assay, results are available in less than 90 minutes, which includes only 10–15 minutes of assay prep.
The Simple Plex cartridges are able to detect even the lowest-abundance targets, helping to deliver industry-leading sensitivity down to the sub-picogram level. Customizable cartridges can assay up to 8 analytes simultaneously with just 25 µL of sample. All assays are fully validated, highly sensitive, and feature up to 4 logs of dynamic range. Ella has a rapidly growing assay menu consisting of over 250 analytes and is expanding to support therapeutic areas across neuroscience, cell and gene therapy, immunology, and cancer.
For labs engaged in biopharmaceutical development, Ella will expedite analysis of protein expression, quantification, and characterization. In clinical research labs, Ella and Simple Plex can be used to analyze biological samples and identify disease biomarkers. No matter the application, the result is the same: faster turnaround times, higher sample throughput, minimal user intervention, and reduced potential for errors or inconsistencies.
Bio-Techne recently revealed that over 1,000 labs are already reaping the benefits of assay automation via Ella. To celebrate this milestone, Bio-Techne invites you to discover the confidence and convenience the platform can bring to your research. The company is offering new academic customers Ella’s precision multiplexing capabilities for as little as $29,500—20% off its regular price—as well as a 20% discount on cartridges for six months. New industry customers are eligible for 20% off Ella. There has never been a better time to upgrade your lab and accelerate discovery with faster and more efficient assays.